Group One Trading’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.73M Buy
109,100
+104,100
+2,082% +$2.93M 0.01% 1800
2025
Q4
$157K Sell
5,000
-4,800
-49% -$159K ﹤0.01% 4604
2025
Q3
$350K Buy
9,800
+200
+2% +$9.13K ﹤0.01% 4064
2025
Q2
$553K Sell
9,600
-7,300
-43% -$413K ﹤0.01% 3306
2025
Q1
$985K Buy
16,900
+10,400
+160% +$710K ﹤0.01% 2475
2024
Q4
$523K Buy
6,500
+5,200
+400% +$444K ﹤0.01% 3140
2024
Q3
$104K Sell
1,300
-10,400
-89% -$739K ﹤0.01% 4144
2024
Q2
$715K Sell
11,700
-900
-7% -$53.5K ﹤0.01% 2269
2024
Q1
$623K Sell
12,600
-4,200
-25% -$200K ﹤0.01% 2531
2023
Q4
$704K Buy
16,800
+15,400
+1,100% +$524K ﹤0.01% 2785
2023
Q3
$45.9K Sell
1,400
-8,400
-86% -$286K ﹤0.01% 5178
2023
Q2
$346K Buy
9,800
+8,100
+476% +$268K ﹤0.01% 3399
2023
Q1
$48.3K Sell
1,700
-1,700
-50% -$60K ﹤0.01% 4877
2022
Q4
$141K Buy
3,400
+1,100
+48% +$47.2K ﹤0.01% 4146
2022
Q3
$95K Buy
+2,300
New +$91.7K ﹤0.01% 4826

Other funds holding PRCT

Group One Trading's PRCT Position: Q1 2026 in Review

Group One Trading sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 4,287 shares — an estimated $121K sold.

Group One Trading first reported a position in PRCT in Q4 2023 and held it in 5 quarters. The position peaked at $390K in Q3 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Group One Trading reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 4,287 Procept Biorobotics shares in Q1 2026, an estimated $121K.
  • Group One Trading first reported a position in Procept Biorobotics in Q4 2023 and held it in 5 quarters.
  • Group One Trading's Procept Biorobotics position peaked at $390K in Q3 2024.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.